Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer

Bruce Montgomery; Philip Lavori; Mark Garzotto; Kelvin Lee; Mary Brophy; Surai Thaneemit-Chen; William Kelly; Joseph Basler; Robert Ringer; Wei Yu; Alice Whittemore; Daniel W. Lin

doi:10.1016/j.urology.2008.02.050

Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer

Bruce Montgomery
, Philip Lavori
, Mark Garzotto
, Kelvin Lee
, Mary Brophy
, Surai Thaneemit-Chen
, William Kelly
, Joseph Basler
, Robert Ringer
, Wei Yu
, Alice Whittemore
, Daniel W. Lin

Department of Urology

Research output: Contribution to journal › Review article › peer-review

18 Scopus citations

Original language	English (US)
Pages (from-to)	474-480
Number of pages	7
Journal	Urology
Volume	72
Issue number	3
DOIs	https://doi.org/10.1016/j.urology.2008.02.050
State	Published - Sep 2008

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.urology.2008.02.050

Cite this

Montgomery, B., Lavori, P., Garzotto, M., Lee, K., Brophy, M., Thaneemit-Chen, S., Kelly, W., Basler, J., Ringer, R., Yu, W., Whittemore, A., & Lin, D. W. (2008). Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer. Urology, 72(3), 474-480. https://doi.org/10.1016/j.urology.2008.02.050

Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer. / Montgomery, Bruce; Lavori, Philip; Garzotto, Mark et al.
In: Urology, Vol. 72, No. 3, 09.2008, p. 474-480.

Research output: Contribution to journal › Review article › peer-review

Montgomery, B, Lavori, P, Garzotto, M, Lee, K, Brophy, M, Thaneemit-Chen, S, Kelly, W, Basler, J, Ringer, R, Yu, W, Whittemore, A & Lin, DW 2008, 'Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer', Urology, vol. 72, no. 3, pp. 474-480. https://doi.org/10.1016/j.urology.2008.02.050

Montgomery B, Lavori P, Garzotto M, Lee K, Brophy M, Thaneemit-Chen S et al. Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer. Urology. 2008 Sep;72(3):474-480. doi: 10.1016/j.urology.2008.02.050

@article{708e0f940212472599697ca64351cbdc,

title = "Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer",

author = "Bruce Montgomery and Philip Lavori and Mark Garzotto and Kelvin Lee and Mary Brophy and Surai Thaneemit-Chen and William Kelly and Joseph Basler and Robert Ringer and Wei Yu and Alice Whittemore and Lin, \{Daniel W.\}",

note = "Funding Information: This work was supported by the Department of Veterans Affairs, Cooperative Studies Program. ",

year = "2008",

month = sep,

doi = "10.1016/j.urology.2008.02.050",

language = "English (US)",

volume = "72",

pages = "474--480",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Veterans Affairs Cooperative Studies Program Study 553

T2 - Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer

AU - Montgomery, Bruce

AU - Lavori, Philip

AU - Garzotto, Mark

AU - Lee, Kelvin

AU - Brophy, Mary

AU - Thaneemit-Chen, Surai

AU - Kelly, William

AU - Basler, Joseph

AU - Ringer, Robert

AU - Yu, Wei

AU - Whittemore, Alice

AU - Lin, Daniel W.

N1 - Funding Information: This work was supported by the Department of Veterans Affairs, Cooperative Studies Program.

PY - 2008/9

Y1 - 2008/9

UR - https://www.scopus.com/pages/publications/50249089542

UR - https://www.scopus.com/pages/publications/50249089542#tab=citedBy

U2 - 10.1016/j.urology.2008.02.050

DO - 10.1016/j.urology.2008.02.050

M3 - Review article

C2 - 18407333

AN - SCOPUS:50249089542

SN - 0090-4295

VL - 72

SP - 474

EP - 480

JO - Urology

JF - Urology

IS - 3

ER -

Veterans Affairs Cooperative Studies Program Study 553: Chemotherapy After Prostatectomy, a Phase III Randomized Study of Prostatectomy Versus Prostatectomy with Adjuvant Docetaxel for Patients with High-Risk, Localized Prostate Cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this